TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Capra Science Antibodies AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,233
|
5,459
|
5,633 |
Financial expenses |
36
|
11
|
7 |
Earnings before taxes |
203
|
642
|
608 |
EBITDA |
585
|
901
|
819 |
Total assets |
3,948
|
4,501
|
3,208 |
Current assets |
1,972
|
2,610
|
1,880 |
Current liabilities |
985
|
1,762
|
1,411 |
Equity capital |
2,576
|
2,256
|
1,796 |
- share capital |
101
|
95
|
98 |
Employees (average) |
3
![]() |
3
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
65.2%
|
50.1%
|
56.0% |
Turnover per employee |
1,744
|
1,820
|
1,408 |
Profit as a percentage of turnover |
3.9%
|
11.8%
|
10.8% |
Return on assets (ROA) |
6.1%
|
14.5%
|
19.2% |
Current ratio |
200.2%
|
148.1%
|
133.2% |
Return on equity (ROE) |
7.9%
|
28.5%
|
33.9% |
Change turnover |
-613
|
-5
|
416 |
Change turnover % |
-10%
|
0%
|
8% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-25%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.